Topic

Articles

Perspectives from a board member and an aspiring board member on how to increase the number of qualified women on boards.

Female Board Members Are Good for Business

Agility and better decisions depend on managing risk and gaining insights from data by prioritizing patient and end-user needs. Companies of all sizes, including GSK, Boehringer-Ingelheim, Sanofi, AstraZeneca, and AbbVie, share best practices.

Mastering Patient Centricity’s Moving Parts: Innovators Share Real-World Examples 

New regulations may require regulators to explore new payment options.

Instead of Drug Spending Caps, Medicare Should Try Value-Based Contracting

New MMIT research highlights payers’ continued hesitancy toward PDTs. Here’s what manufacturers need to know.

When Will Payers Improve Coverage of Prescription Digital Therapeutics?

Amidst lack of funding for women’s health research, industry must collaborate now to advance RMMH.

It’s Time to Invest in Reproductive Medicine and Maternal Health 

Senior Director of Patient Advocacy, Catalyst Pharmaceuticals

A roadmap for cohering patient perspectives.

An Integrated Patient Advocacy Strategy With Transparent Communication

Seth Lederman, MD, is a physician-scientist and CEO of New Jersey-based Tonix Pharmaceuticals, a company developing technologies to prevent COVID-19 and treat long COVID. His research led to the discovery of the CD40 ligand and its role in T-cell helper function.

Industry must continue research and development to combat the pandemic.

Why Are We Surrendering to COVID?

Investments setting up sector for future success that could one day rival its US counterpart.

A New Era in European Life Sciences Investment

Approval of Medicare and Medicaid coverage for digital therapeutics represents next step in advancing care for mental health patients.

Opinion